Michael J. Lyerly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael J. Lyerly has a total of 161 co-authors. Here are the top co-authors by number of shared publications:
- Karen C. Albright
National Telestroke Program, Department of Veteran Affairs, Washington, DC
24 shared publications April Sisson
14 shared publications- Amelia K. Boehme
Department of Neurology, Columbia University School of Medicine, New York, NY (S.P., A.K.B.).
12 shared publications Niren Kapoor
Division of Neurocritical Care, Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA
8 shared publicationsReza Bavarsad Shahripour
Comprehensive Stroke Center, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA
8 shared publications- Toby Gropen
University of Alabama At Birmingham Birmingham AL United States
8 shared publications
Latest Publications
- 30 October 2024
- Published by Springer Nature
- p. 377-382
Discharge Planning
- 30 October 2024
- Published by Springer Nature
- p. 143-147
Disposition Decisions
- 22 March 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 31 (6) , 106424
Educational Intervention in the Emergency Department to Address Disparities in Stroke Knowledge
- 22 March 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 31 (6) , 106424
Educational Intervention in the Emergency Department to Address Disparities in Stroke Knowledge
- Open Access
- 3 February 2022
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 6 (1) , e12
Race and in-hospital mortality after spontaneous intracerebral hemorrhage in the Stroke Belt: Secondary analysis of a case-control study – CORRIGENDUM
[This corrects the article DOI: 10.1017/cts.2021.21.].
- 3 February 2022
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 6 (1) , e12
Open AccessRace and in-hospital mortality after spontaneous intracerebral hemorrhage in the Stroke Belt: Secondary analysis of a case-control study – CORRIGENDUM
[This corrects the article DOI: 10.1017/cts.2021.21.].
- 1 September 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (9) , 105930
Neuroimaging Considerations in Patients with Chronic Kidney Disease
- 1 September 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (9) , 105930
Neuroimaging Considerations in Patients with Chronic Kidney Disease
- 18 March 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (9) , 105725
Acute Stroke Care for Patients with Chronic Kidney Disease
- 18 March 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (9) , 105725
Acute Stroke Care for Patients with Chronic Kidney Disease
- Open Access
- 16 March 2021
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 5 (1) , 1-31
Race and in-hospital mortality after spontaneous intracerebral hemorrhage in the Stroke Belt: Secondary analysis of a case–control study
Background and Purpose: Intracerebral hemorrhage (ICH) accounts for around 10% of stroke, but carries 50% of stroke mortality. ICH characteristics and prognostic factors specific to the Stroke Belt are not well defined by race. Methods: Records of patients admitted to the University of Alabama Hospital with ICH from 2017 to 2019 were reviewed. We examined the association of demographics; clinical and radiographic features including stroke severity, hematoma volume, and ICH score; and transfer status with in-hospital mortality and discharge functional status for a biracial population including Black and White patients. Independent predictors of in-hospital mortality and functional outcome were examined using logistic regression. Results: Among the 275 ICH cases included in this biracial analysis, Black patients (n = 114) compared to White patients (n = 161) were younger (60.6 vs. 71.4 years, P < 0.0001), more often urban (81% vs. 64%, P < 0.01), more likely to have a history of hypertension (87% vs. 71%, P < 0.01), less often transferred (44% vs. 74%, P < 0.01), and had smaller median initial hematoma volumes (9.1 vs. 12.6 mL, P = 0.041). On multivariable analysis, Glasgow Coma Scale (GCS) for White patients (OR 13.0, P < 0.0001), hyperlipidemia for Black patients (OR 13.9, P = 0.019), and ICH volume for either race (Black patients: OR 1.05, P = 0.03 and White patients: OR 1.04, P < 0.01) were independent predictors of in-hospital mortality. Conclusions: Hypertension is more prevalent among Black ICH patients in the Stroke Belt. The addition of hyperlipidemia to the ICH score model improved the prediction of mortality for Black ICH patients. No differences in in-hospital mortality or poor functional outcome were observed by race.
- 16 March 2021
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 5 (1) , 1-31
Open AccessRace and in-hospital mortality after spontaneous intracerebral hemorrhage in the Stroke Belt: Secondary analysis of a case–control study
Background and Purpose: Intracerebral hemorrhage (ICH) accounts for around 10% of stroke, but carries 50% of stroke mortality. ICH characteristics and prognostic factors specific to the Stroke Belt are not well defined by race. Methods: Records of patients admitted to the University of Alabama Hospital with ICH from 2017 to 2019 were reviewed. We examined the association of demographics; clinical and radiographic features including stroke severity, hematoma volume, and ICH score; and transfer status with in-hospital mortality and discharge functional status for a biracial population including Black and White patients. Independent predictors of in-hospital mortality and functional outcome were examined using logistic regression. Results: Among the 275 ICH cases included in this biracial analysis, Black patients (n = 114) compared to White patients (n = 161) were younger (60.6 vs. 71.4 years, P < 0.0001), more often urban (81% vs. 64%, P < 0.01), more likely to have a history of hypertension (87% vs. 71%, P < 0.01), less often transferred (44% vs. 74%, P < 0.01), and had smaller median initial hematoma volumes (9.1 vs. 12.6 mL, P = 0.041). On multivariable analysis, Glasgow Coma Scale (GCS) for White patients (OR 13.0, P < 0.0001), hyperlipidemia for Black patients (OR 13.9, P = 0.019), and ICH volume for either race (Black patients: OR 1.05, P = 0.03 and White patients: OR 1.04, P < 0.01) were independent predictors of in-hospital mortality. Conclusions: Hypertension is more prevalent among Black ICH patients in the Stroke Belt. The addition of hyperlipidemia to the ICH score model improved the prediction of mortality for Black ICH patients. No differences in in-hospital mortality or poor functional outcome were observed by race.
- 23 November 2020
- Published by Wolters Kluwer Health in Stroke
- Vol. 52 (1) , 253-259
Provider Communication and Telepresence Enhance Veteran Satisfaction With Telestroke Consultations
Background and Purpose: Telestroke has been demonstrated to be a cost-effective means to expand access to care and improve outcomes in stroke; however, information on patient perceptions of this system of care delivery are limited. This study seeks to examine patient feedback of a national telestroke system within the Veterans Health Administration. Methods: Patients who received a telestroke consultation were eligible for a phone interview 2 weeks later, including questions about technology quality, telepresence, and telestroke provider communication. Satisfaction scores ranged from 1 to 7 (higher=more satisfied) and for analyses were dichotomized as 6 to 7 indicating high satisfaction versus P P P P =0.02). In the multivariate model, telepresence (odds ratio, 3.10 [95% CI, 1.81–5.31]) and provider ratings (odds ratio, 2.37 [95% CI, 1.20–4.68]) were independently associated with satisfaction. Veterans who were satisfied were more likely to recommend the technology ( P <0.0001). Conclusions: Provider qualities, including telepresence and provider ratings, were associated with overall Veteran satisfaction with the telestroke consultation. Technology quality may be necessary but not sufficient to impact patient experience. Training providers to improve telepresence could improve patient experience with telestroke consultation.
- 23 November 2020
- Published by Wolters Kluwer Health in Stroke
- Vol. 52 (1) , 253-259
Provider Communication and Telepresence Enhance Veteran Satisfaction With Telestroke Consultations
Background and Purpose: Telestroke has been demonstrated to be a cost-effective means to expand access to care and improve outcomes in stroke; however, information on patient perceptions of this system of care delivery are limited. This study seeks to examine patient feedback of a national telestroke system within the Veterans Health Administration. Methods: Patients who received a telestroke consultation were eligible for a phone interview 2 weeks later, including questions about technology quality, telepresence, and telestroke provider communication. Satisfaction scores ranged from 1 to 7 (higher=more satisfied) and for analyses were dichotomized as 6 to 7 indicating high satisfaction versus P P P P =0.02). In the multivariate model, telepresence (odds ratio, 3.10 [95% CI, 1.81–5.31]) and provider ratings (odds ratio, 2.37 [95% CI, 1.20–4.68]) were independently associated with satisfaction. Veterans who were satisfied were more likely to recommend the technology ( P <0.0001). Conclusions: Provider qualities, including telepresence and provider ratings, were associated with overall Veteran satisfaction with the telestroke consultation. Technology quality may be necessary but not sufficient to impact patient experience. Training providers to improve telepresence could improve patient experience with telestroke consultation.
- 1 August 2019
- Vol. 36 (8) , 365-369
Quality of Care for Veterans With In-Hospital Stroke.
Veterans who develop an in-hospital stroke and those who present to the emergency department with stroke symptoms received similar care, but some differences suggest the need to better standardize stroke care regardless of care setting.
- 1 August 2019
- Vol. 36 (8) , 365-369
Quality of Care for Veterans With In-Hospital Stroke.
Veterans who develop an in-hospital stroke and those who present to the emergency department with stroke symptoms received similar care, but some differences suggest the need to better standardize stroke care regardless of care setting.
- 1 April 2019
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 9 (2) , 140-144
Role of CYP2C19 alleles in the management of recurrent ischemic stroke
Purpose of review CYP2C19 is the primary enzyme involved in the activation of clopidogrel, an antiplatelet agent used for secondary stroke prevention. An individual9s CYP2C19 alleles are used to understand their CYP2C19-clopidogrel metabolizer phenotype. Single nucleotide polymorphisms of the CYP2C19 gene result in altered metabolism of this prodrug. Recent findings Three ischemic stroke cases were treated with clopidogrel. Despite confirming adequate drug exposure, medication adherence, and ruling out drug-drug interactions, all had recurrent ischemic stroke. Each case had a CYP2C19 *2/*17 genotype, categorizing them as intermediate clopidogrel metabolizers. Even with the gain-of-function allele, the loss-of-function allele resulted in lack of prodrug activation, leading to decreased efficacy in platelet inhibition. Summary These cases illustrate the importance of a thoughtful approach to secondary stroke prevention and demonstrate the utility of pharmacogenomic testing in clopidogrel hyporesponders. Recognition of the importance of CYP2C19 genotyping has the potential to enable better selection of appropriate secondary prevention strategies.
- 1 April 2019
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 9 (2) , 140-144
Role of CYP2C19 alleles in the management of recurrent ischemic stroke
Purpose of review CYP2C19 is the primary enzyme involved in the activation of clopidogrel, an antiplatelet agent used for secondary stroke prevention. An individual9s CYP2C19 alleles are used to understand their CYP2C19-clopidogrel metabolizer phenotype. Single nucleotide polymorphisms of the CYP2C19 gene result in altered metabolism of this prodrug. Recent findings Three ischemic stroke cases were treated with clopidogrel. Despite confirming adequate drug exposure, medication adherence, and ruling out drug-drug interactions, all had recurrent ischemic stroke. Each case had a CYP2C19 *2/*17 genotype, categorizing them as intermediate clopidogrel metabolizers. Even with the gain-of-function allele, the loss-of-function allele resulted in lack of prodrug activation, leading to decreased efficacy in platelet inhibition. Summary These cases illustrate the importance of a thoughtful approach to secondary stroke prevention and demonstrate the utility of pharmacogenomic testing in clopidogrel hyporesponders. Recognition of the importance of CYP2C19 genotyping has the potential to enable better selection of appropriate secondary prevention strategies.